StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)

Close on Nov 17, 2026Market cap $50.42MP/E –Yield –

Tonix Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Tonix Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$152.99M. For fiscal 2025 it was -$99.84M. The highest annual figure on record is -$1.23M in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$99.84M–
FY2024Dec 31, 2024-$60.93M–
FY2023Dec 31, 2023-$102.00M–
FY2022Dec 31, 2022-$98.05M–
FY2021Dec 31, 2021-$75.56M–
FY2020Dec 31, 2020-$48.57M–
FY2019Dec 31, 2019-$26.68M–
FY2018Dec 31, 2018-$23.97M–
FY2017Dec 31, 2017-$19.13M–
FY2016Dec 31, 2016-$37.31M–
FY2015Dec 31, 2015-$42.53M–
FY2014Dec 31, 2014-$22.84M–
FY2013Dec 31, 2013-$8.52M–
FY2012Dec 31, 2012-$5.71M–
FY2011Dec 31, 2011-$2.64M–
FY2010Dec 31, 2010-$1.23M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$42.24M–
Q1 FY2026Mar 31, 2026-$42.32M–
Q4 FY2025Dec 31, 2025-$39.65M–
Q3 FY2025Sep 30, 2025-$28.78M–
Q2 FY2025Jun 30, 2025-$14.83M–
Q1 FY2025Mar 31, 2025-$16.58M–
Q4 FY2024Dec 31, 2024-$14.63M–
Q3 FY2024Sep 30, 2024-$18.80M–
Q2 FY2024Jun 30, 2024-$9.92M–
Q1 FY2024Mar 31, 2024-$17.58M–
Q4 FY2023Dec 31, 2023-$22.34M–
Q3 FY2023Sep 30, 2023-$23.39M–
Q2 FY2023Jun 30, 2023-$23.37M–
Q1 FY2023Mar 31, 2023-$32.91M–
Q4 FY2022Dec 31, 2022-$22.30M–
Q3 FY2022Sep 30, 2022-$23.54M–
Q2 FY2022Jun 30, 2022-$21.17M–
Q1 FY2022Mar 31, 2022-$31.05M–
Q4 FY2021Dec 31, 2021-$22.45M–
Q3 FY2021Sep 30, 2021-$12.95M–
Q2 FY2021Jun 30, 2021-$19.11M–
Q1 FY2021Mar 31, 2021-$21.06M–
Q4 FY2020Dec 31, 2020-$13.91M–
Q3 FY2020Sep 30, 2020-$15.29M–
Q2 FY2020Jun 30, 2020-$10.04M–
Q1 FY2020Mar 31, 2020-$9.33M–
Q4 FY2019Dec 31, 2019-$6.68M–
Q3 FY2019Sep 30, 2019-$6.65M–
Q2 FY2019Jun 30, 2019-$4.71M–
Q1 FY2019Mar 31, 2019-$8.64M–
Q4 FY2018Dec 31, 2018-$6.82M–
Q3 FY2018Sep 30, 2018-$4.89M–
Q2 FY2018Jun 30, 2018-$5.49M–
Q1 FY2018Mar 31, 2018-$6.77M–
Q4 FY2017Dec 31, 2017-$4.93M–
Q3 FY2017Sep 30, 2017-$5.05M–
Q2 FY2017Jun 30, 2017-$4.36M–
Q1 FY2017Mar 31, 2017-$4.79M–
Q4 FY2016Dec 31, 2016-$5.44M–
Q3 FY2016Sep 30, 2016-$8.39M–

More Tonix Pharmaceuticals figures

See a number that looks wrong?